Unknown

Dataset Information

0

Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure.

ABSTRACT: Mitochondrial (mt) DNA depletion and oxidative mtDNA damage have been implicated in the process of pathological cardiac remodeling. Whether these features are present in the early phase of maladaptive cardiac remodeling, that is, during compensated cardiac hypertrophy, is still unknown. We compared the morphologic and molecular features of mt biogenesis and markers of oxidative stress in human heart from adult subjects with compensated hypertrophic cardiomyopathy and heart failure. We have shown that mtDNA depletion is a constant feature of both conditions. A quantitative loss of mtDNA content was associated with significant down-regulation of selected modulators of mt biogenesis and decreased expression of proteins involved in mtDNA maintenance. Interestingly, mtDNA depletion characterized also the end-stage phase of cardiomyopathies due to a primary mtDNA defect. Oxidative stress damage was detected only in failing myocardium.

SUBMITTER: Pisano A 

PROVIDER: S-EPMC4758811 | biostudies-other | 2016 Mar-Apr

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure.

Pisano Annalinda A   Cerbelli Bruna B   Perli Elena E   Pelullo Maria M   Bargelli Valentina V   Preziuso Carmela C   Mancini Massimiliano M   He Langping L   Bates Matthew G D MG   Lucena Joaquin R JR   Della Monica Paola Lilla PL   Familiari Giuseppe G   Petrozza Vincenzo V   Nediani Chiara C   Taylor Robert W RW   d'Amati Giulia G   Giordano Carla C  

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 20150930 2

Mitochondrial (mt) DNA depletion and oxidative mtDNA damage have been implicated in the process of pathological cardiac remodeling. Whether these features are present in the early phase of maladaptive cardiac remodeling, that is, during compensated cardiac hypertrophy, is still unknown. We compared the morphologic and molecular features of mt biogenesis and markers of oxidative stress in human heart from adult subjects with compensated hypertrophic cardiomyopathy and heart failure. We have shown  ...[more]